John Waldeisen net worth
Quick answer
John Waldeisen's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. John Waldeisen is CEO at Lucira Health. Lucira Health valuation.
John Waldeisen is CEO at Lucira Health (YC W15). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Education: B.S. Engineering Science, Penn State (2007); Ph.D. Bioengineering, University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Diagnostics
- Team size: 43
- Website: https://www.lucirahealth.com/
Who is John Waldeisen?
John Waldeisen is a co-founder of Lucira Health (originally Diassess), a company that developed the first FDA-approved at-home COVID-19 test. He holds a bachelor's degree in engineering science from Penn State and a doctoral degree in bioengineering from the University of...
Highlights:
- B.S. Engineering Science, Penn State (2007)
- Ph.D. Bioengineering, University of California, Berkeley
- Co-founded Lucira Health, which joined Y-Combinator in 2015 and received FDA app
About Lucira Health
Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in...
FAQ: John Waldeisen net worth and Lucira Health valuation
What is John Waldeisen's net worth?
John Waldeisen's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. John Waldeisen is CEO at Lucira Health. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Lucira Health valuation?
Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is John Waldeisen's role?
John Waldeisen is CEO at Lucira Health, a Y Combinator-backed startup (batch W15).